Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2026 Filed Apr 30, 2026 10:11 UTC |
Schadel Christopher RyanChief Marketing Officer
|
GrantRestricted Stock Units · Derivative | 9,868 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-003326 · ownership.xml · derivative · entry 2 Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,868 Underlying: Common Stock · 9,868 shares Expires not disclosed F2 · security: Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. F2 · derivative.exercise_date: Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. F2 · derivative.expiration_date: Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 10:11 UTC |
Schadel Christopher RyanChief Marketing Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $15.20 | $0.00 |
DisclosureSEC source: 0001683168-26-003326 · ownership.xml · derivative · entry 1 Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-04-27 F1 · security: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. F1 · derivative.exercise_date: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 10:13 UTC |
Sohn Adam CraigDirector
|
GrantRestricted Stock Units · Derivative | 9,868 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-003328 · ownership.xml · derivative · entry 1 Sohn Adam Craig · CIK 0002113700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,868 Underlying: Common Stock · 9,868 shares Expires not disclosed F1 · security: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. F1 · derivative.exercise_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. F1 · derivative.expiration_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 10:10 UTC |
Halabu David EliasDirector · Co-Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $15.20 | $0.00 |
DisclosureSEC source: 0001683168-26-003324 · ownership.xml · derivative · entry 1 Halabu David Elias · CIK 0002110997 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2036-04-27 F1 · security: On April 27, 2026, the issuer and the reporting person entered into an Amended and Restated Executive Employment Agreement (the "A&R Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 500,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(d) of the A&R Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. F1 · derivative.exercise_date: On April 27, 2026, the issuer and the reporting person entered into an Amended and Restated Executive Employment Agreement (the "A&R Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 500,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(d) of the A&R Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 10:08 UTC |
Fuerst Bryan EricDirector
|
GrantRestricted Stock Units · Derivative | 9,868 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-003322 · ownership.xml · derivative · entry 1 Fuerst Bryan Eric · CIK 0002111012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,868 Underlying: Common Stock · 9,868 shares Expires not disclosed F1 · security: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. F1 · derivative.exercise_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. F1 · derivative.expiration_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 10:07 UTC |
Cooper Kenneth LyleDirector
|
GrantRestricted Stock Units · Derivative | 9,868 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-003320 · ownership.xml · derivative · entry 1 Cooper Kenneth Lyle · CIK 0002111618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,868 Underlying: Common Stock · 9,868 shares Expires not disclosed F1 · security: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. F1 · derivative.exercise_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. F1 · derivative.expiration_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 10:05 UTC |
Burke Michelle EllenDirector · Co-Chief Executive Officer
|
GrantCommon Stock | 16,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-003316 · ownership.xml · nonDerivative · entry 1 Burke Michelle Ellen · CIK 0002114401 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,447 F1 · security: On April 27, 2026, the issuer entered into an Amendment to Service Agreement with the reporting person, pursuant to which the issuer agreed to issue $1,000,000 worth of shares of the issuer's common stock to the reporting person, payable in four equal quarterly tranches. The shares reported herein represent the first such tranche, issued pursuant to the Z Squared, Inc. 2025 Incentive Compensation Plan. The number of shares reported was determined by dividing $250,000 by the closing price per share of the issuer's common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). Read SEC document |
| April 27, 2026 Filed Aug 20, 2026 10:01 UTC |
Schadel Christopher RyanChief Marketing Officer
|
GrantRestricted Stock Units · Derivative | 9,868 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001185185-26-003631 · ownership.xml · derivative · entry 4 Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,868 Underlying: Common Stock · 9,868 shares Expires not disclosed F3 · security: In addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. F3 · derivative.exercise_date: In addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. F3 · derivative.expiration_date: In addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. Read SEC document |
| April 27, 2026 Filed Aug 20, 2026 10:01 UTC |
Schadel Christopher RyanChief Marketing Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $15.20 | $0.00 |
DisclosureSEC source: 0001185185-26-003631 · ownership.xml · derivative · entry 3 Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-04-27 F2 · security: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. F2 · derivative.exercise_date: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:00 UTC |
Cogley BrianChief Financial Officer
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001032 · ownership.xml · nonDerivative · entry 2 Cogley Brian · CIK 0002008384 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:00 UTC |
Cogley BrianChief Financial Officer
|
Exercise / conversionCommon stock | 10,000 | $10.56 | $105,600.00 |
DisclosureSEC source: 0001683168-26-001032 · ownership.xml · nonDerivative · entry 1 Cogley Brian · CIK 0002008384 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Salkind GeneDirector
|
GrantCommon Stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001025 · ownership.xml · nonDerivative · entry 2 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,161 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. F3 · ownership.direct: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Salkind GeneDirector
|
Exercise / conversionCommon stock | 5,700 | $10.56 | $60,192.00 |
DisclosureSEC source: 0001683168-26-001025 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. F3 · ownership.direct: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:00 UTC |
Deschamps PhilippeDirector
|
GrantCommon Stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001031 · ownership.xml · nonDerivative · entry 2 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:00 UTC |
Deschamps PhilippeDirector
|
Exercise / conversionCommon stock | 5,700 | $10.56 | $60,192.00 |
DisclosureSEC source: 0001683168-26-001031 · ownership.xml · nonDerivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Calise ChrisDirector
|
GrantCommon stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001030 · ownership.xml · nonDerivative · entry 2 Calise Chris · CIK 0001824769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,741 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. F3 · ownership.direct: Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Calise ChrisDirector
|
Exercise / conversionCommon stock | 5,700 | $10.56 | $60,192.00 |
DisclosureSEC source: 0001683168-26-001030 · ownership.xml · nonDerivative · entry 1 Calise Chris · CIK 0001824769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. F3 · ownership.direct: Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
GrantCommon Stock | 51,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001029 · ownership.xml · nonDerivative · entry 2 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,192 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
Exercise / conversionCommon stock | 148,875 | $7.05 | $1,049,568.75 |
DisclosureSEC source: 0001683168-26-001029 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the weighted average exercise price of shares purchased upon exercise of stock options. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Cochran Christopher P.Director
|
GrantCommon Stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001026 · ownership.xml · nonDerivative · entry 2 Cochran Christopher P. · CIK 0001951916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Cochran Christopher P.Director
|
Exercise / conversionCommon stock | 5,700 | $10.56 | $60,192.00 |
DisclosureSEC source: 0001683168-26-001026 · ownership.xml · nonDerivative · entry 1 Cochran Christopher P. · CIK 0001951916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Yerace Daniel AlexanderDirector · VP Operations
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001028 · ownership.xml · nonDerivative · entry 2 Yerace Daniel Alexander · CIK 0001846625 · Director · VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,531 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Yerace Daniel AlexanderDirector · VP Operations
|
Exercise / conversionCommon stock | 10,000 | $10.41 | $104,100.00 |
DisclosureSEC source: 0001683168-26-001028 · ownership.xml · nonDerivative · entry 1 Yerace Daniel Alexander · CIK 0001846625 · Director · VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the weighted average exercise price of shares purchased upon exercise of stock options. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
DeSilva TaraDirector
|
GrantCommon Stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001027 · ownership.xml · nonDerivative · entry 2 DeSilva Tara · CIK 0001952535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
DeSilva TaraDirector
|
Exercise / conversionCommon stock | 5,700 | $10.56 | $60,192.00 |
DisclosureSEC source: 0001683168-26-001027 · ownership.xml · nonDerivative · entry 1 DeSilva Tara · CIK 0001952535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Sheehy Christine EliseVP Compliance and Secy
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001024 · ownership.xml · nonDerivative · entry 2 Sheehy Christine Elise · CIK 0001846632 · VP Compliance and Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,031 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC |
Sheehy Christine EliseVP Compliance and Secy
|
Exercise / conversionCommon stock | 1,000 | $10.56 | $10,560.00 |
DisclosureSEC source: 0001683168-26-001024 · ownership.xml · nonDerivative · entry 1 Sheehy Christine Elise · CIK 0001846632 · VP Compliance and Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the exercise price of shares purchased upon exercise of stock options. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 17:29 UTC |
Cogley BrianChief Financial Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 10,000 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001395 · ownership.xml · derivative · entry 1 Cogley Brian · CIK 0002008384 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 10,000 non-qualified stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:28 UTC |
Salkind GeneDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 5,700 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001392 · ownership.xml · derivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Underlying: Common Stock · 5,700 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:29 UTC |
Yerace Daniel AlexanderDirector · VP of Operations
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 5,000 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001394 · ownership.xml · derivative · entry 1 Yerace Daniel Alexander · CIK 0001846625 · Director · VP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,000 non-qualified stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:28 UTC |
Sheehy Christine EliseVP Compliance and Secy
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 1,000 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001393 · ownership.xml · derivative · entry 1 Sheehy Christine Elise · CIK 0001846632 · VP Compliance and Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 1,000 non-qualified stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:27 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 28,875 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001391 · ownership.xml · derivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,125 Underlying: Common Stock · 28,875 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 28,875 non-qualified stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:27 UTC |
DeSilva TaraDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 5,700 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001390 · ownership.xml · derivative · entry 1 DeSilva Tara · CIK 0001952535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Underlying: Common Stock · 5,700 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:26 UTC |
Cochran Christopher P.Director
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 5,700 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001389 · ownership.xml · derivative · entry 1 Cochran Christopher P. · CIK 0001951916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Underlying: Common Stock · 5,700 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:26 UTC |
Calise ChrisDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 5,700 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001388 · ownership.xml · derivative · entry 1 Calise Chris · CIK 0001824769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Underlying: Common Stock · 5,700 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| March 04, 2025 Filed Mar 10, 2025 21:23 UTC |
Deschamps PhilippeDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 5,700 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001475 · ownership.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,950 Underlying: Common Stock · 5,700 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 01:14 UTC |
DeSilva TaraDirector
|
PurchaseCommon Stock | 1,800 | $0.58 | $1,044.00 |
DisclosureSEC source: 0001683168-24-000319 · ownership.xml · nonDerivative · entry 2 DeSilva Tara · CIK 0001952535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,266 F1 · balance_after: Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 01:14 UTC |
DeSilva TaraDirector
|
PurchaseCommon Stock | 466 | $0.56 | $260.96 |
DisclosureSEC source: 0001683168-24-000319 · ownership.xml · nonDerivative · entry 1 DeSilva Tara · CIK 0001952535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,466 F1 · balance_after: Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 10, 2024 Filed Jan 17, 2024 16:03 UTC |
Cogley BrianChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $0.67 | $3,350.00 |
DisclosureSEC source: 0001683168-24-000329 · ownership.xml · nonDerivative · entry 1 Cogley Brian · CIK 0002008384 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · balance_after: Includes 25,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:30 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
PurchaseCommon Stock | 14,004 | $0.66 | $9,242.64 |
DisclosureSEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 3 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,782,615 F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:30 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
PurchaseCommon Stock | 6,000 | $0.67 | $4,020.00 |
DisclosureSEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 2 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,768,611 F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 22:31 UTC |
Salkind GeneDirector
|
PurchaseCommon Stock | 11,600 | $0.69 | $8,004.00 |
DisclosureSEC source: 0001683168-24-000161 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,056 F1 · balance_after: Includes (i) 95,817 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of common stock issuable upon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares of common stock that are issuable upon currently exercisable warrants and (iv) 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 22:32 UTC |
Yerace Daniel AlexanderDirector · VP of Operations
|
PurchaseCommon Stock | 10,850 | $0.69 | $7,486.50 |
DisclosureSEC source: 0001683168-24-000163 · ownership.xml · nonDerivative · entry 1 Yerace Daniel Alexander · CIK 0001846625 · Director · VP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,071,455 F1 · balance_after: Includes 50,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 22:30 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
PurchaseCommon Stock | 5,050 | $0.69 | $3,484.50 |
DisclosureSEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,762,611 F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 22:30 UTC |
Cochran Christopher P.Director
|
PurchaseCommon Stock | 7,000 | $0.77 | $5,390.00 |
DisclosureSEC source: 0001683168-24-000157 · ownership.xml · nonDerivative · entry 1 Cochran Christopher P. · CIK 0001951916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 F1 · balance_after: Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:01 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
GiftCommon Stock | 700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-008778 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,757,561 F1 · acquired: The listed shares were transferred to an estate planning trust that has an independent trustee, for the benefit of the Reporting Person's children and for no consideration. The Reporting Person does not serve as trustee of this trust nor does he have or share investment control over the listed shares held by this trust. The Reporting Person disclaims beneficial ownership of the shares held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the listed shares for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 19:15 UTC |
Salkind GeneDirector
|
PurchaseCommon Stock | 4,006 | $1.01 | $4,046.06 |
DisclosureSEC source: 0001683168-23-006169 · ownership.xml · nonDerivative · entry 3 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 4,046 F3 · ownership.nature: Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee. Read SEC document |
| August 25, 2023 Filed Aug 30, 2023 19:15 UTC |
Salkind GeneDirector
|
PurchaseCommon Stock | 28,638 | $0.91 | $26,060.58 |
DisclosureSEC source: 0001683168-23-006169 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 28,638 F1 · ownership.nature: The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the trustee. Read SEC document |
| August 23, 2023 Filed Aug 31, 2023 20:01 UTC |
Calise ChrisDirector
|
PurchaseCommon Stock | 2,582 | $0.94 | $2,418.56 |
DisclosureSEC source: 0001683168-23-006200 · ownership.xml · nonDerivative · entry 2 Calise Chris · CIK 0001824769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,464,897 F1 · balance_after: Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days. Read SEC document |
| August 23, 2023 Filed Aug 31, 2023 20:01 UTC |
Calise ChrisDirector
|
PurchaseCommon Stock | 9,000 | $0.94 | $8,460.00 |
DisclosureSEC source: 0001683168-23-006200 · ownership.xml · nonDerivative · entry 1 Calise Chris · CIK 0001824769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,462,315 F1 · balance_after: Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.